Background In 2019, the United States experienced a nationwide outbreak of e-cigarette, or
vaping, product use-associated lung injury (EVALI). More than one-half of these patients …

Update: Characteristics of Patients in a National Outbreak of E-cigarette, or Vaping, Product
Use–Associated Lung Injuries — United States, October 2019 | MMWR Skip directly to site …

Compared with other EVALI patients, rehospitalized patients and patients who died after
hospital discharge were more likely to have one or more chronic conditions, including …

Update: Interim Guidance for Health Care Providers for Managing Patients with Suspected E-cigarette,
or Vaping, Product Use–Associated Lung Injury — United States, November 2019 | MMWR …

Abstract Background As of January 7, 2020, a total of 2558 hospitalized patients with
nonfatal cases and 60 patients with fatal cases of e-cigarette, or vaping, product use …

In a recent examination of rehospitalization and death among previously hospitalized
patients with e-cigarette or vaping, product use–associated lung injury (EVALI), at least one …

Summary Background Since June, 2019, more than 1000 new cases of e-cigarette, or
vaping, product use associated lung injury (EVALI) have been reported in the USA. Patients …

Update: Interim Guidance for Health Care Providers Evaluating and Caring for Patients with
Suspected E-cigarette, or Vaping, Product Use Associated Lung Injury — United States, October …

The 2019 national outbreak of e-cigarette, or vaping, product use-associated lung injury
(EVALI) reported by 25 state health departments included hundreds of reported cases. By …

Since August 2019, the pulmonary disease termed e‐cigarette or vaping product‐use
associated lung injury (EVALI), has resulted in 2758 hospitalizations and 64 deaths in the …